Adtralza Tralokinumab 150 mg/1 ml - 4 Pre‑filled Syringes

Product Overview:

• Adtralza (Tralokinumab) 4 prefilled syringes is used to treat moderate-to-severe eczema in adults and children aged 12 years and older that is not responding well to prescription topical eczema treatments or in those who cannot use topical treatments. It is self-administered subcutaneously by injection under the skin every other week.
• Tralokinumab can be used alone or with topical corticosteroids.


• The autoinjector is for use only in adults. The prefilled syringe is for use in adults and children at least 12 years old.


• Tralokinumab’s mechanism of action involves targeting interleukin 13 (IL-13), a protein that contributes to inflammation. Tralokinumab works by binding to IL-13, preventing it from interacting with its receptor and releasing proinflammatory cytokines, chemokines, and IgE. It belongs to the drug class called interleukin-13 (IL-13) inhibitors.

How It Works:

• Skin lesions, itchiness, and other symptoms of atopic dermatitis (eczema) are caused in part by inflammation. Tralokinumab works by blocking a protein that triggers inflammation.

Benefits:

• Tralokinumab is commonly used to treat a skin condition called atopic dermatitis . Tralokinumab may be used if your eczema is moderate to severe and topical treatments that you apply to the skin have not helped enough or cannot be used.

Directions for Use:

• It is administered by subcutaneous injection (under the skin). The starting dose is usually 600 mg (four injections), followed by 300 mg (two injections) every two weeks. Your healthcare provider will show you how to prepare and inject it. Ask your doctor or pharmacist for advice.

Active Ingredients : 

• Tralokinumab 150 mg

Side Effects:

• Infection in the nose or throat, or common cold symptoms


• Itchy, inflamed, or red eyes


• Pain, itching, swelling, or redness near the injection site


• High eosinophil count (a type of white blood cell)

Cautions & Warnings:

• Do not use Tralokinumab unless it has been prescribed to you by a health care provider. Use it as prescribed.


• Do not share Tralokinumab with other people, even if they have the same condition as you. It may harm them.


• Keep Tralokinumab out of the reach of children. Since this medicine may be stored in a refrigerator, take special care to keep it away from children who also use the refrigerator.

Pregnancy Warnings : 

• It is not known if or how Tralokinumab could affect pregnancy or harm a fetus. Tell your health care provider if you are or plan to become pregnant. They will let you know if you should use Tralokinumab while you are pregnant or trying to get pregnant.

Breastfeeding Warnings : 

• It is not known if Tralokinumab passes into breast milk. Tell your health care provider if you are breastfeeding or plan to breastfeed. Your health care provider will let you know if you should use Tralokinumab while breastfeeding.

Storage:

• You may store Tralokinumab at room temperature, up to 86 F (30 C), for a maximum of 14 days. Do not place Tralokinumab back in the refrigerator after it has been left out at room temperature. Dispose of any unused Tralokinumab if it is kept at room temperature for longer than 14 days.


• Store Tralokinumab in the original carton to protect it from light. Do not freeze, shake, or place it in direct sunlight.

FAQ:

• Q . Does Tralokinumab interact with foods or drinks?


• A . There are no known interactions between Tralokinumab and foods or drinks.


• It is unknown if drinking alcohol will affect Tralokinumab .


• Q . Does Tralokinumab interact with other medicines (drug interactions)?


• A . There are no known interactions between Tralokinumab and other medicines. Always tell your health care provider about any prescription or over-the-counter (OTC) medicines, vitamins/minerals, herbal products, and other supplements you are using.


• Q . What should I do if I miss a dose of Tralokinumab ?


• A . If you miss a dose, use it as soon as possible. Then continue Tralokinumab at your usual dose at the next regular time.